![Joseph Jimenez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Jimenez
Directeur/Membre du Conseil chez
GENERAL MOTORS COMPANY
Fortune : 9 M $ au Aujourd'hui
Profil
M. Joseph Jimenez est un administrateur indépendant de Graphite Bio, un président de Century Therapeutics LLC, un administrateur et directeur général d'Aditum Bio Fund 1 LP, un administrateur indépendant de Procter & Gamble Co. et un administrateur indépendant de General Motors Co. et un président de la Fédération européenne des industries pharmaceutiques et des associations. Il siège au conseil d'administration de Graphite Bio, Aditum Bio Fund 1 LP, Procter & Gamble Co. et General Motors Co. Auparavant, M. Jimenez a été employé en tant que président élu par Pharmaceutical Research & Manufacturers of America, administrateur indépendant par Colgate-Palmolive Co., président par Speedel Holding AG, administrateur général par Novartis Pharma Schweiz AG, directeur général par Novartis AG, directeur général par Novartis Consumer Health, Inc, directeur non exécutif chez AstraZeneca Plc, vice-président exécutif chez H.J. Heinz Co, président, directeur général et vice-président exécutif chez Heinz Europe Ltd, président et directeur général chez Heinz North America Consumer Products, président et vice-président senior chez ConAgra Foods, Inc, directeur général chez Novartis Pharmaceuticals Corp et président chez Speedel Pharma AG. Il a également siégé au conseil d'administration de uBiome, Inc, Blue Nile, Inc, Pinnacle Foods Finance LLC et Pinnacle Foods Group LLC. Il a obtenu son diplôme de premier cycle à l'université de Stanford et un MBA à l'université de Californie, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/06/2026 | 37 016 ( 0 % ) | 5 M $ | 31/05/2026 | |
| 06/04/2026 | 32 330 ( 0 % ) | 3 M $ | 31/05/2026 | |
| 12/06/2025 | 494 345 ( 0,27 % ) | 1 M $ | 31/05/2026 | |
-.--% | 05/06/2026 | 72 498 ( -.--% ) | - $ | Aujourd'hui |
Dernières actualités sur Joseph Jimenez
| 04/09/17 | Le DG de Novartis quittera ses fonctions en 2018 | RE |
Postes actifs de Joseph Jimenez
| Sociétés | Poste | Début |
|---|---|---|
| GENERAL MOTORS COMPANY | Directeur/Membre du Conseil | 09/06/2015 |
| PROCTER & GAMBLE COMPANY | Directeur/Membre du Conseil | 01/03/2018 |
Teres Bio, Inc.
 Teres Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage life sciences company which develops novel therapies for skin diseases | Directeur/Membre du Conseil | - |
Anteris Bio, Inc.
 Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of renal disease | Directeur/Membre du Conseil | - |
Via Nova Therapeutics, Inc.
 Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for acute and sub acute viral infections | Directeur/Membre du Conseil | - |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur/Membre du Conseil | - |
Aditum Bio Management Co. LLC
 Aditum Bio Management Co. LLC Investment ManagersFinance Aditum Bio Management Co. LLC is an active manager. | Fondateur | - |
Aditum Bio Fund 1 LP
 Aditum Bio Fund 1 LP Investment ManagersFinance Functions as a venture capital fund | Directeur/Membre du Conseil | 01/07/2019 |
Anciens postes connus de Joseph Jimenez
| Sociétés | Poste | Fin |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Président | 14/08/2025 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Joseph Jimenez
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
31
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 31 |
|---|---|
Colgate-Palmolive Co.
 Colgate-Palmolive Co. Household/Personal CareConsumer Non-Durables Manufactures and sells oral, personal, home care & pet nutritional products | Consumer Non-Durables |
Conagra Brands, Inc.
 Conagra Brands, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food company that engages in food making business | Consumer Non-Durables |
Procter & Gamble Co.
 Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Blue Nile, Inc.
 Blue Nile, Inc. Specialty StoresRetail Trade Retails diamonds and jewelry through online | Retail Trade |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Researches and develops vaccines for viral diseases | Commercial Services |
Pinnacle Foods Group LLC
 Pinnacle Foods Group LLC Food: Specialty/CandyConsumer Non-Durables Manufactures, markets and distributes frozen food products | Consumer Non-Durables |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Heinz North America Consumer Products
 Heinz North America Consumer Products Food: Specialty/CandyConsumer Non-Durables Manufactures snack foods | Consumer Non-Durables |
Speedel Holding AG
 Speedel Holding AG Pharmaceuticals: MajorHealth Technology Produces medicines | Health Technology |
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cardiovascular and metabolic diseases | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Pinnacle Foods Finance LLC
 Pinnacle Foods Finance LLC Food: Major DiversifiedConsumer Non-Durables Manufactures and distributes convenience food products | Consumer Non-Durables |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Novartis Consumer Health, Inc.
 Novartis Consumer Health, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
General Motors Co.
 General Motors Co. Motor VehiclesConsumer Durables Develops, manufactures and markets cars, trucks and automobile parts | Consumer Durables |
Heinz Europe Ltd. | |
The Blackstone Group
 The Blackstone Group Investment ManagersFinance Provides investment advisory services | Finance |
uBiome, Inc.
 uBiome, Inc. BiotechnologyHealth Technology Operates as a microbiome company | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Aditum Bio Fund 1 LP
Aditum Bio Fund 1 LP Investment ManagersFinance Functions as a venture capital fund | Finance |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
Aditum Bio Management Co. LLC
Aditum Bio Management Co. LLC Investment ManagersFinance Aditum Bio Management Co. LLC is an active manager. | Finance |
Century Therapeutics, Inc. /Old/
 Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Via Nova Therapeutics, Inc.
Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for acute and sub acute viral infections | Health Technology |
Teres Bio, Inc.
Teres Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage life sciences company which develops novel therapies for skin diseases | Health Technology |
Anteris Bio, Inc.
Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of renal disease | Health Technology |
